ID: ALA2441105

Max Phase: Preclinical

Molecular Formula: C19H15NO4

Molecular Weight: 321.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc(Oc2ccc(O)cc2)cc1)c1ccccc1O

Standard InChI:  InChI=1S/C19H15NO4/c21-14-7-11-16(12-8-14)24-15-9-5-13(6-10-15)20-19(23)17-3-1-2-4-18(17)22/h1-12,21-22H,(H,20,23)

Standard InChI Key:  RBEMVAFKFYHQIB-UHFFFAOYSA-N

Associated Targets(non-human)

Androgen Receptor 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.33Molecular Weight (Monoisotopic): 321.1001AlogP: 4.14#Rotatable Bonds: 4
Polar Surface Area: 78.79Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.92CX Basic pKa: CX LogP: 3.96CX LogD: 3.84
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: -0.63

References

1. Yamada A, Fujii S, Mori S, Kagechika H..  (2013)  Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.,  (10): [PMID:24900588] [10.1021/ml4001744]

Source